Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04RPI
|
||||
Former ID |
DNC013156
|
||||
Drug Name |
Dmt-Pro-Trp-D-2-Nal-NH2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528646] | ||
Structure |
Download2D MOL |
||||
Formula |
C40H44N6O5
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1O)C)CC(C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC<br />=C43)C(=O)NC(CC5=CC6=CC=CC=C6C=C5)C(=O)N)N
|
||||
InChI |
1S/C40H44N6O5/c1-23-16-26(17-24(2)36(23)47)19-31(41)40(51)46-15-7-12-35(46)39(50)45-34(21-29-22-43-32-11-6-5-10-30(29)32)38(49)44-33(37(42)48)20-25-13-14-27-8-3-4-9-28(27)18-25/h3-6,8-11,13-14,16-18,22,31,33-35,43,47H,7,12,15,19-21,41H2,1-2H3,(H2,42,48)(H,44,49)(H,45,50)/t31-,33+,34-,35-/m0/s1
|
||||
InChIKey |
DAHITVLHYSLLFU-ZFOKTMFVSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528646] | |
Mu-type opioid receptor | Target Info | Inhibitor | [528646] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.